Cancer Care Payment Reform Act of 2017
Do you support it?
Want to know if it passes?
We'll email you when S 463 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on S 463.
You're tracking S 463
We'll email you the moment it moves.
S 463 — Cancer Care Payment Reform Act of 2017
Last action — Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1502-1504)
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 115th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Cancer Care Payment Reform Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to establish the Oncology Medical Home Demonstration Project, through which the Centers for Medicare & Medicaid Services (CMS) shall make special payments to participating oncology practices that coordinate patient care and meet other specified requirements. During the first two years of the project, CMS shall pay a care coordination management fee to each such practice. After the third, fourth, and fifth years of the project, CMS shall pay a performance incentive payment to each participating practice that meets or exceeds performance standards developed by CMS. CMS shall assess the performance of each participating oncology practice annually. Performance standards shall address: (1) specified measures related to patient care, resource utilization, survivorship, and end-of-life care; and (2) the patient experience of care, as reflected in surveys submitted by each practice. CMS shall also assess the extent to which a practice has used breakthrough or other best-in-class therapies. To the extent practicable, CMS shall select practices of varying sizes and geographic areas for participation.
Bill Text
- Introduced Introduced in Senate Current html February 28, 2017
Compared against current U.S. Code AI-generated reading aid — verify against the official bill.
The bill establishes a new Oncology Medical Home Demonstration Project under Medicare to improve cancer care quality and cost efficiency.
-
Title XVIII of the Social Security Act
SEC. 1866F. ONCOLOGY MEDICAL HOME DEMONSTRATION PROJECT.
This section creates a new demonstration project focusing on oncology care.
-
Title XVIII of the Social Security Act
(a) Establishment of Demonstration Project.--Not later than 12 months after the date of the enactment of this section, the Secretary shall establish an Oncology Medical Home Demonstration Project (in this section referred to as the 'demonstration project') to make payments in the amounts specified in subsection (f) to each participating oncology practice (as defined in subsection (b)).
It mandates the establishment of a demonstration project for oncology practices within a 12-month timeframe.
-
Title XVIII of the Social Security Act
(b) Definition of Participating Oncology Practice.--For purposes of this section, the term 'participating oncology practice' means an oncology practice that-- (1) submits to the Secretary an application to participate in the demonstration project in accordance with subsection (c); (2) is selected by the Secretary, in accordance with subsection (d), to participate in the demonstration project; and (3) is owned by a physician, or is owned by or affiliated with a hospital, that submitted a claim for payment in the prior year for an item or service for which payment may be made under part B.
It defines what constitutes a participating oncology practice for the demonstration project.
-
Title XVIII of the Social Security Act
(c) Application To Participate.--An application by an oncology practice to participate in the demonstration project shall include an attestation to the Secretary that the practice--
It outlines the requirements an oncology practice must meet to apply for participation.
-
Title XVIII of the Social Security Act
Measures.-- (1) Development.--(A) In general.--The Secretary shall use measures described in paragraph (2), and may use measures developed under paragraph (3), to assess the performance of each participating oncology practice, as compared to other participating oncology practices as described in paragraph (4)(A)(i).
It requires the development of performance measures to evaluate participating oncology practices.
Action History
-
Introduced in Senate
-
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1502-1504)
Sponsors
- John Cornyn · Primary
- Thomas R. Carper · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 1 co-sponsors · 545 not signed on
Sponsors (1)
- Cornyn, John Republican
Co-sponsors (1)
- Carper, Thomas R. Democratic
Not signed on (545)
545 members have not signed on to this bill.
Show all 545 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S 463 do?
- Cancer Care Payment Reform Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to establish the Oncology Medical Home Demonstration Project, through which the Centers for Medicare & Medicaid Services (CMS) shall make special payments to participating oncology practices that coordinate patient care and meet other specified requirements. During the first two years of the project, CMS shall pay a care coordination management fee to each such practice. After the third, fourth, and fifth years of the project, CMS shall pay a performance incentive payment to each participating practice that meets or exceeds performance standards developed by CMS. CMS shall assess the performance of each participating oncology practice annually. Performance standards shall address: (1) specified measures related to patient care, resource utilization, survivorship, and end-of-life care; and (2) the patient experience of care, as reflected in surveys submitted by each practice. CMS shall also assess the extent to which a practice has used breakthrough or other best-in-class therapies. To the extent practicable, CMS shall select practices of varying sizes and geographic areas for participation.
- Who sponsors S 463?
- S 463 is sponsored by Cornyn, John (Republican) and Carper, Thomas R. (Democratic).
- What is the current status of S 463?
- This bill died with 115th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track S 463?
- Track S 463 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S 463
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S 463
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →